1. Home
  2. BOLT vs ARBB Comparison

BOLT vs ARBB Comparison

Compare BOLT & ARBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • ARBB
  • Stock Information
  • Founded
  • BOLT 2015
  • ARBB 1997
  • Country
  • BOLT United States
  • ARBB Singapore
  • Employees
  • BOLT N/A
  • ARBB N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • ARBB EDP Services
  • Sector
  • BOLT Health Care
  • ARBB Technology
  • Exchange
  • BOLT Nasdaq
  • ARBB Nasdaq
  • Market Cap
  • BOLT 16.8M
  • ARBB 18.5M
  • IPO Year
  • BOLT 2021
  • ARBB 2023
  • Fundamental
  • Price
  • BOLT $0.40
  • ARBB $0.74
  • Analyst Decision
  • BOLT Hold
  • ARBB
  • Analyst Count
  • BOLT 5
  • ARBB 0
  • Target Price
  • BOLT $1.13
  • ARBB N/A
  • AVG Volume (30 Days)
  • BOLT 146.4K
  • ARBB 2.5M
  • Earning Date
  • BOLT 05-13-2025
  • ARBB 04-26-2025
  • Dividend Yield
  • BOLT N/A
  • ARBB N/A
  • EPS Growth
  • BOLT N/A
  • ARBB N/A
  • EPS
  • BOLT N/A
  • ARBB N/A
  • Revenue
  • BOLT $7,690,000.00
  • ARBB $12,334,474.00
  • Revenue This Year
  • BOLT N/A
  • ARBB N/A
  • Revenue Next Year
  • BOLT $77.45
  • ARBB N/A
  • P/E Ratio
  • BOLT N/A
  • ARBB N/A
  • Revenue Growth
  • BOLT N/A
  • ARBB N/A
  • 52 Week Low
  • BOLT $0.38
  • ARBB $0.22
  • 52 Week High
  • BOLT $1.40
  • ARBB $1.33
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 39.13
  • ARBB 53.95
  • Support Level
  • BOLT $0.38
  • ARBB $0.65
  • Resistance Level
  • BOLT $0.47
  • ARBB $0.83
  • Average True Range (ATR)
  • BOLT 0.04
  • ARBB 0.08
  • MACD
  • BOLT -0.00
  • ARBB -0.01
  • Stochastic Oscillator
  • BOLT 13.27
  • ARBB 47.10

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About ARBB ARB IOT Group Limited

ARB IOT Group Ltd is engaged in provision of hardware and software of Internet of Things Solutions to meet customers' demand in four business lines, which are IoT Smart Home and Buildings, IoT Smart Agriculture, IoT System Development, and IoT Gadget Distribution. The company delivers holistic solutions with full turnkey deployment from designing, installation, testing, pre-commissioning, and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company has two operating segments: Internet of Things ('IoT'), Investment holding and others. It earns its maximum profit from the Internet of Things (IoT) segment.

Share on Social Networks: